Noida: Child PGI will hire 33 specialists for its ophthalmology, transfusion medicine, orthopaedic, genetic disease, neurology, nephrology and cardiology departments by the end of the month. The move is set to benefit more than 3,000 children who are under treatment or consultation at the hospital.According to the hospital administration, the contract of over 12 doctors had ended in October after two-year service.The genetic diseases department, which had only one doctor, had to remain closed for over a month even with more than 1,500 patients waiting for follow-up treatment. An ad hoc arrangement was introduced to make a doctor available once a week for patients, a section of whom came from west UP districts.Started in December 2021 with less than 10 patients, the department of medical genetics is now treating over 1,600 children with rare genetic diseases like beta thalassemia, spinal muscular atrophy, Duchenne muscular dystrophy, cystic fibrosis, inborn errors of metabolism and paediatric neurological disorders are commonly reported in India.Child PGI also arranges expensive medicines for the treatment of genetic diseases from countries, like the USA, which are otherwise out of reach for many families who come for treatment.We also published the following articles recentlyUS FDA approves two gene therapies to treat patients with sickle cell diseaseThe US FDA approved two gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease (SCD) in patients aged 12 years and above. Casgevy is a cell-based gene therapy that utilizes CRISPR/Cas9 technology, while Lyfgenia uses a lentiviral vector for genetic modification. Both therapies are approved for patients with sickle cell disease and a history of vaso-occlusive events. The modified stem cells in these therapies produce HbAT87Q, a gene-therapy-derived haemoglobin that reduces the risk of sickling and blood flow occlusion. These approvals mark an important medical advance in treating severe blood disorders.Director Denis Villeneuve calls Dune 2 more muscularRenowned director Denis Villeneuve discusses his upcoming film Dune: Part Two and promises a shift towards a more action-packed and visually stunning experience. Unlike its predecessor, the sequel was entirely shot using IMAX cameras, elevating the visuals. The first installment was meditative and contemplative, following a young mans journey of discovery, while the sequel focuses more on action. The film features the original cast, including Timothe Chalamet and Zendaya, and introduces newcomers Christopher Walken and Florence Pugh. Villeneuve expresses his aspirations for a third installment and teases progress. The release date has been moved to March 1, 2023, much to the anticipation of fans.Data on medicine requirement of all govt hospitals will be collected by Dec end: SawantState health minister Tanaji Sawant informed the legislative council that by December-end, government hospitals in Maharashtra will be asked to send their annual requirement of medicines for the next financial year. BJP MLC Pravin Datke raised concerns about low medicine stock and problems with diagnostic machines at Nagpurs GMCH and IGGMCH. Medical education minister Hasan Mushrif assured that both hospitals have adequate stock and will address the issues. Sawant mentioned the creation of a new authority for medicine purchase and collecting data of annual requirements. Funding of Rs 13 crore has been approved for Nagpur hospitals. The Haffkine Institute is no longer responsible for medicine procurement.

Stay updated with all the Noida Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.